Kelly Deck - 04 Mar 2024 Form 4 Insider Report for Inhibrx, Inc.

Role
Chief Financial Officer
Signature
/s/ Kelly Deck
Issuer symbol
N/A
Transactions as of
04 Mar 2024
Net transactions value
-$2,571,458
Form type
4
Filing time
06 Mar 2024, 16:41:25 UTC
Previous filing
03 Jan 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Options Exercise $289,250 -8,125 -27% $35.60 21,875 04 Mar 2024 Common Stock 8,125 $23.30 Direct F1
transaction INBX Stock Option (right to buy) Options Exercise $1,910,113 -53,958 -77% $35.40 16,042 04 Mar 2024 Common Stock 53,958 $33.63 Direct F2
transaction INBX Stock Option (right to buy) Options Exercise $372,095 -10,417 -52% $35.72 9,583 05 Mar 2024 Common Stock 10,417 $34.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F3 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 11, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.